Xermelo® is a tryptophan hydroxylase inhibitor indicated for the treatment of
carcinoid syndrome diarrhea in combination with somatostatin analog (SSA)
therapy in adults inadequately controlled by SSA therapy
XERMELO®
Product not available for Sale


